Theralase Technologies Inc. (TLT) — Cash Flow Reinvestment Rate

Latest as of September 2018: 0.05x

Theralase Technologies Inc. (TLT) has a Cash Flow Reinvestment Rate of 0.05x as of September 2018, reinvesting CA$19.98K (capex CA$19.98K ) from operating cash flow of CA$436.21K. See cash generation quality of Theralase Technologies Inc. to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.05x

(Capex + Investments) / Operating CF

Total Reinvested

CA$19.98K

Capex + Investments

Operating Cash Flow

CA$436.21K

CAD

Capital Expenditures

CA$19.98K

CAD

Theralase Technologies Inc. Cash Flow Reinvestment Rate (2005–2005)

Historical reinvestment intensity for Theralase Technologies Inc. across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Theralase Technologies Inc..

Annual Cash Flow Reinvestment Rate for Theralase Technologies Inc. (2005–2005)

Year-by-year capital reinvestment analysis for Theralase Technologies Inc.. See TLT financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (CAD)	Operating CF	Capex	YoY Change
2005	1.00x	CA$85.30K	CA$85.33K	CA$85.30K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow